JPRN-UMIN000019017已完成未知
Efficacy of Rho-kinase inhibitor ophthalmic solution on bleb formation after trabeculectomy, a randomized parallel study - Efficacy of Rho-kinase inhibitor ophthalmic solution after trabeculectomy
Department of Ophthalmology, Hiroshima University Hospital0 个研究点目标入组 122 人开始时间: 2015年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 122
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who had intraocular surgeries within six months. 2) Patients whose intraocular pressure are not able to be measured by Goldmann applanation tonometer. 3) Patients who had conjunctival surgeries (including glaucoma surgeries). 4) Patients who have an allergy to the ingredients of Rho-kinase inhibitor ophthalmic solution. 5) Patients who used Rho-kinase inhibitor ophthalmic solution before surgery. 6) Patients under the pregnancy or nursing. 7) Patients who are determined as an unsuitable person for this study by the doctor.
研究者
相似试验
Unknown
3 期
Efficacy of the ROCK inhibitor for corneal endothelial protection in Fuchs' endothelial corneal dystrophy after cataract surgeryendothelial cell loss in cataract surgery in Fuchs endothelial corneal dystrophyTCTR20220602005THE 90TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND ( Ratchadaphiseksomphot Endowment Fund)56
已完成
不适用
The effect of Rho kinase inhibitor on corneal endothelial dysfunction: the 1st stepCorneal endothelial dysfunctionJPRN-UMIN000003624Department of Ophthalmology, Kyoto Prefectural University of Medicine10
Unknown
早期 1 期
Short-term Effect of Rho-kinase Inhibitor on Retinal CirculationGlaucoma, Open-AngleNCT04234932University of the Incarnate Word10
尚未招募
不适用
Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator.retinal vein occlusion retinal artery occlusionJPRN-UMIN000024593Kyoto Prefectual Univercity of Medicine10
Unknown
2 期
A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical InterventionGlaucomaNCT02174991New York Glaucoma Research Institute10